Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS

As part of consolidating the cancer care of four Western Australian public services into a single, multi-disciplinary facility, the clinics will transition from their existing oncology information systems (OIS) to Elekta's MOSAIQ® OIS. The conversion to MOSAIQ for radiation oncology, hematology/medical oncology and pediatric oncology at the Queen Elizabeth II Medical Centre (QEIIMC), Perth, WA, will occur in stages from mid-2015 to 2016.

The consolidation comprises the Sir Charles Gairdner Hospital, Princess Margaret Hospital and the new Children's Hospital. The QEIIMC is the largest medical center in the southern hemisphere and globally recognized for its health care, research and education.

"Locating all of these services under one roof in the new cancer center is a major advantage; but the hospital needed a coordinated, central approach to information management, common to all cancer services and in support of about 500 cancer center staff," says Andrew Wilson, Managing Director, Elekta Australia. "MOSAIQ is the optimal solution to satisfy that requirement."

MOSAIQ advantages

Today, over two thirds of radiation oncology departments in Australia rely on MOSAIQ OIS. Officials at the four clinics spent several months evaluating many of these departments and their use of MOSAIQ – both its features and its performance. In addition to compatibility with virtually all linear accelerators (linacs), including the medical center's Varian linacs and a CyberKnife treatment system, the following aspects of Elekta and MOSAIQ were critical in their decision to change to a new OIS, according to Wilson:

  • Elekta support for MOSAIQ in Australia
  • Pharmaceutical benefits scheme supported by MOSAIQ
  • Available billing system interface available with MOSAIQ
  • Patient scheduling and tracking system interface available with MOSAIQ
  • Comprehensive training on MOSAIQ available
  • ANALYTIQ™, Elekta's data analysis tool for data mining and decision support
  • Availability of data migration.

"MOSAIQ is the OIS of choice for both public and private providers in Western Australia and the country in general," Wilson adds. "Its open systems architecture gives centers the flexibility to integrate existing systems and leaves open choices for future technology decisions."

Source:

Elekta

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elekta. (2023, September 12). Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS. News-Medical. Retrieved on April 16, 2024 from https://www.news-medical.net/news/20150119/Elekta-helps-new-Australian-cancer-center-make-seamless-transition-to-MOSAIQ-OIS.aspx.

  • MLA

    Elekta. "Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS". News-Medical. 16 April 2024. <https://www.news-medical.net/news/20150119/Elekta-helps-new-Australian-cancer-center-make-seamless-transition-to-MOSAIQ-OIS.aspx>.

  • Chicago

    Elekta. "Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS". News-Medical. https://www.news-medical.net/news/20150119/Elekta-helps-new-Australian-cancer-center-make-seamless-transition-to-MOSAIQ-OIS.aspx. (accessed April 16, 2024).

  • Harvard

    Elekta. 2023. Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS. News-Medical, viewed 16 April 2024, https://www.news-medical.net/news/20150119/Elekta-helps-new-Australian-cancer-center-make-seamless-transition-to-MOSAIQ-OIS.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma